Bone Loss after Allogeneic Haematopoietic Stem Cell Transplantation: A Pilot Study on the Use of Zoledronic Acid

Figure 3

T-score (mean ± SD) of lumbar spine (a) and femur hip (b) after treatment with zoledronic acid.

(a) Lumbar spine: baseline −1.99 (±1.20), 1 year −1.41 (±1.49), 2 years −0.85 (±1.48)

(b) Femur hip: baseline −1.88 (±0.83), 1 year −1.53 (±0.86), 2 years −1.18 (±0.70)